Replacement Heart-Conduit Valve Implanted Without Surgery
|
By HospiMedica International staff writers Posted on 08 Feb 2010 |

Image: The Melody Transcatheter Pulmonary Valve Therapy (photo courtesy Medtronic).
An innovative transcatheter pulmonary valve (TPV) offers a nonsurgical valve replacement option for patients with congenital heart disease (CHD).
The Melody TPV is delivered through a catheter requiring only a small incision, and should benefit children and adults born with a malformation of the pulmonary valve. Deep coaptation of the Melody TPV leaflets provides valve competency across a range of diameters and geometries, and natural venous valve leaflets open and close under minimal pressure for optimal hemodynamics. Sutures at every node of the TPV are designed to enhance valve integrity. The Melody TPV is delivered via the Ensemble transcatheter delivery system, using fluoroscopic guidance. The 22 French delivery catheter offers a low crossing profile, and a balloon-in-balloon deployment enables minor adjustments to facilitate accurate placement. A unique coverage sheath protects the valve during delivery up to the point of deployment.
Similar to other conduits, the Melody TPV does not cure the heart condition and over time may wear and require replacement. But since it is implanted without open heart surgery, it can prop open the poorly functioning conduit and can keep blood flowing in the proper direction, which will allow a patient's conduit to function longer than usual, delaying the need for more invasive open-heart surgery. The Melody TPV and the Ensemble delivery system are products of Medtronic (Minneapolis, MN, USA), and have received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).
"The Melody Transcatheter Pulmonary Valve is a significant technological breakthrough and offers a reprieve for many patients with congenital heart disease – many of whom are young and will require several heart surgeries over their lifetime,” said pediatric cardiologist William Hellenbrand, M.D., of Columbia University Medical Center (New York, NY, USA). "The Melody valve gives patients with congenital heart disease a new, nonsurgical approach to managing their disease.”
Conduits are surgically implanted valves used to treat patients with congenital heart defects that have narrowed, leaky, or missing pulmonary valves that impede the proper flow of blood from the heart's right ventricle to the pulmonary artery, which then sends the blood on to the lungs for oxygenation.
Related Links:
Medtronic
The Melody TPV is delivered through a catheter requiring only a small incision, and should benefit children and adults born with a malformation of the pulmonary valve. Deep coaptation of the Melody TPV leaflets provides valve competency across a range of diameters and geometries, and natural venous valve leaflets open and close under minimal pressure for optimal hemodynamics. Sutures at every node of the TPV are designed to enhance valve integrity. The Melody TPV is delivered via the Ensemble transcatheter delivery system, using fluoroscopic guidance. The 22 French delivery catheter offers a low crossing profile, and a balloon-in-balloon deployment enables minor adjustments to facilitate accurate placement. A unique coverage sheath protects the valve during delivery up to the point of deployment.
Similar to other conduits, the Melody TPV does not cure the heart condition and over time may wear and require replacement. But since it is implanted without open heart surgery, it can prop open the poorly functioning conduit and can keep blood flowing in the proper direction, which will allow a patient's conduit to function longer than usual, delaying the need for more invasive open-heart surgery. The Melody TPV and the Ensemble delivery system are products of Medtronic (Minneapolis, MN, USA), and have received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).
"The Melody Transcatheter Pulmonary Valve is a significant technological breakthrough and offers a reprieve for many patients with congenital heart disease – many of whom are young and will require several heart surgeries over their lifetime,” said pediatric cardiologist William Hellenbrand, M.D., of Columbia University Medical Center (New York, NY, USA). "The Melody valve gives patients with congenital heart disease a new, nonsurgical approach to managing their disease.”
Conduits are surgically implanted valves used to treat patients with congenital heart defects that have narrowed, leaky, or missing pulmonary valves that impede the proper flow of blood from the heart's right ventricle to the pulmonary artery, which then sends the blood on to the lungs for oxygenation.
Related Links:
Medtronic
Latest Surgical Techniques News
- 3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
- CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
- Small Cryoprobe Outperforms Forceps in Lung Biopsy Trial
- Natural Bypass Score May Guide Care in Chronic Coronary Blockages
- Navigation Instruments Cleared for Posterior Cervical Fusion Procedures
- Bioengineered Heart Patch Improves Cardiac Function in Advanced Heart Failure
- Fracture Plating System Combines Anatomical Fit with Streamlined Instrumentation
- Surgical Robotic System Gains CE Mark for Minimally Invasive Procedures
- Pink Noise Stimulation Approach Could Support Safer Anesthesia
- BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
- Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment
- Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
- FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
- Intravascular Lithotripsy Catheter Advances Treatment of Calcified Coronary Disease
- Handheld AI Endomicroscope Enables Real-Time Precancer Detection at Point of Care
- Photoacoustic Imaging System Maps Hidden Nerves and Vessels in Robotic Laparoscopy
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read moreCritical Care
view channel
Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
Atrial fibrillation, an irregular and often rapid heart rhythm, is the most common arrhythmia in adults. Elective electrical cardioversion is frequently canceled on the day of treatment when patients revert... Read more
New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
Benign prostatic hyperplasia is a noncancerous enlargement of the prostate that can cause lower urinary tract symptoms and impair daily functioning. These symptoms erode sleep, productivity, and sexual... Read more
Bedside CSF Monitor Detects Early Infection in Fluid Drains
External drainage of cerebrospinal fluid (CSF) after traumatic brain injury, hydrocephalus, or hemorrhage carries a significant risk of infection. These infections can prolong intensive care, cause severe... Read more
Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
Cardiac arrhythmias, including slow and irregular heart rhythms, often require pacemakers that are surgically implanted. While effective, implants carry procedural risks and long-term device maintenance burdens.... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read morePoint of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







